Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign
Genes · 2026
DOI: 10.3390/genes17101290 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2026. Verfasst von Isabella Mullally und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, US…. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Malignant Hyperthermia, Rhabdomyolysis. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense.
Abstract (Originalsprache)
Malignant Hyperthermia Susceptibility (MHS) is most commonly caused by pathogenic variants in the RYR1 gene. The proliferation of RYR1 Variants of Uncertain Significance (VUS) on diagnostic genetic panels poses a significant clinical challenge, often leading to unnecessarily complex clinical concerns. We report the case of a 27-year-old African American female with a personal history of recurrent exertional rhabdomyolysis found to have a heterozygous RYR1 c.13230G>C p.(Glu4410Asp) variant. She later tested negative via the gold-standard Caffein–Halothane Contracture Test (CHCT). A negative CHCT test with an in silico Rare Exome Variant Ensemble Learner (REVEL) score of 0.171 meets the ClinGen MHS Variant Curation Expert Panel (VCEP) criteria for reclassification of the variant to Likely Benign. Additionally, the high allele frequency isolated within the African American (AA) population suggests a benign, ancestry-specific polymorphism maintained within the AA population rather than a pathogenic MHS mutation. Therefore, reclassifying the variant to Likely Benign prevents unnecessary muscle biopsies and alterations to perioperative anesthetic management and reduces the need for family cascade testing, and reduces use of potentially suboptimal alternative anesthetic protocols.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA.
- Defense and Veterans Consortium for Integrative Pain Management, Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD 20817, USA.
- Brenner Children's Hospital, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
- Center for Precision Health Research, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Neurology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Rd., Bethesda, MD 20814, USA.
ORCID-Profile: Isabella Mullally, Peter Bedocs, Thomas Pranikoff, Robert Vietor, Alakesh Bera
Förderung
- United States Department of Defense
Zitieren
APA
Mullally, I., Smith, E., Bedocs, P., Pranikoff, T., Biesecker, L. G., Cook, G. A., Vietor, R., & Bera, A. (2026). Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign. Genes. https://doi.org/10.3390/genes17101290
Vancouver
Mullally I, Smith E, Bedocs P, Pranikoff T, Biesecker LG, Cook GA, et al. Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign. Genes. 2026. doi:10.3390/genes17101290
BibTeX
@article{Mullally2026,
author = {Mullally, Isabella and Smith, Eugene and Bedocs, Peter and Pranikoff, Thomas and Biesecker, Leslie G and Cook, Glen A and Vietor, Robert and Bera, Alakesh},
title = {Phenotypic Evidence for the Reclassification of the RYR1 p.(Glu4410Asp) Variant: From Uncertain Significance to Likely Benign},
journal = {Genes},
year = {2026},
doi = {10.3390/genes17101290}
}
EUVIMED